Sir,

Neurogenic stunned myocardium (NSM) is defined as myocardial injury and dysfunction occurring after various types of acute brain injury due to central autonomic disorders. After taking consent from next of kin we present a case of NSM following subarachnoid bleed managed at our hospital. A 60-year-old female without any history of significant comorbidities presented to one healthcare facility with a history of sudden loss of consciousness and respiratory distress. On examination, she was hypotensive having diffuse ST-T changes on electrocardiogram (ECG) with transthoracic echocardiography revealing global hypokinesia, gross systolic dysfunction (ejection fraction - 31%), and Grade II diastolic dysfunction. Quantitative troponin level was 1736 ng/L. After stabilization with ventilator support and inotropes, she underwent plain computed tomography (CT) scan which revealed massive acute subarachnoid bleed \[[Figure 1](#F1){ref-type="fig"}\]. Her condition continued to improve over the next day when she underwent CT angiography revealing right-sided middle cerebral artery aneurysm \[[Figure 2](#F2){ref-type="fig"}\]. She continued to improve dramatically and was referred to our center for further management. On arrival at our hospital, she was hemodynamically stable, conscious, and well oriented. Although ST-T changes were persisting on ECG, repeat echo demonstrated marked improvement in cardiac function and repeat value of troponin came as 0.43 ng/L. She underwent 4-vessel cerebral angiography and coiling of aneurysm under general endotracheal anesthesia uneventfully. Her cardiac status continued to improve over the next few days and was discharged in a hemodynamically and neurologically stable condition. As NSM has commonly been described in patients with subarachnoid hemorrhage,\[[@ref1][@ref2][@ref3][@ref4]\] the majority of NSM data comes from studies concerning this group of patients. Features key to the identification of NSM are fully reversible postischemic dysfunction and that the dysfunction is not caused by a primary defect in myocardial perfusion. Our patient had reversible cardiac dysfunction which is indicative of neurogenic cause mimicking true myocardial injury although coronary angiogram needed to be done to strengthen our diagnosis. The pathomechanism of NSM has not been fully elucidated. It was once assumed that the condition resulted from ischemia of the myocardium caused by the contraction of epicardial coronary vessels and microcirculation disorders. Currently, it is believed that the most likely cause of NSM changes is catecholamine-induced myocardial damage.\[[@ref1][@ref2][@ref5]\] As NSM syndrome has been described only recently, there are no clear guidelines for its management. It is generally believed that treatment directed at the acute cerebral injury underlying NSM is essential.\[[@ref3]\] Further studies are required to broaden our knowledge about the pathomechanisms underlying NSM syndrome and to find the most effective methods of its treatment and prevention. It seems essential to determine the effects of exogenous catecholamines on NSM. Once their negative influence is confirmed, alternative methods of treatment should be sought. As left ventricular dysfunction is frequently associated with subarachnoid bleed, there are a lot of clinical and pathophysiological similarities with transient left ventricular apical ballooning syndrome or takotsubo cardiomyopathy.\[[@ref6]\] Each type of reversible left ventricular dysfunction mediated by the central nervous system and initiated by acute brain injury, both physical, such as intracranial bleeding or head traumas, and psychological, such as sudden emotional stress, could be encompassed in a single definition with larger inclusion criteria, such as "acute ballooning cardiomyopathy" that is likely to be more representative of the real needs in the clinical setting.\[[@ref6]\].
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